Sensus Healthcare Inc
SRTS3.830USD
-0.010-0.26%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
62.97MMarket Cap
LossP/E TTM
More Details of Sensus Healthcare Inc Company
Sensus Healthcare, Inc. is a medical device company that is engaged in the development and delivery of non-invasive treatments for skin cancer and keloids. The Company, leveraging its superficial radiotherapy (SRT and IG-SRT) technology, provides healthcare providers with a patient-centric treatment platform. Its products and services include SRT-100, SRT-100 Vision, SRT-100+, Sentinel service program and others. The SRT-100 is a photon x-ray low energy SRT system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides customers with additional options compared to the SRT-100 base model. These additional options allow for dedicated treatment planning and full treatment progression documentation in a patient’s record. The SRT-100+ offers all the same features as the SRT-100, with the addition of remote diagnostics and other features.
Sensus Healthcare Inc Info
Ticker SymbolSRTS
Company nameSensus Healthcare Inc
IPO dateJun 03, 2016
CEOSardano (Joseph C)
Number of employees35
Security typeOrdinary Share
Fiscal year-endJun 03
Address851 Broken Sound Pkwy NW Ste 215
CityBOCA RATON
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code33487-3635
Phone15619225808
Websitehttps://sensushealthcare.com/
Ticker SymbolSRTS
IPO dateJun 03, 2016
CEOSardano (Joseph C)
Company Executives of Sensus Healthcare Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Joseph C. Sardano
Mr. Joseph C. Sardano
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
1.20M
+2.13%
Mr. Eric Sachetta
Mr. Eric Sachetta
Independent Director
Independent Director
140.11K
--
Mr. Javier Rampolla
Mr. Javier Rampolla
Chief Financial Officer
Chief Financial Officer
40.00K
-1.82%
Ms. Megan Cornish
Ms. Megan Cornish
Non-Employee Independent Director
Non-Employee Independent Director
32.00K
--
Ms. Magdalena Martinez
Ms. Magdalena Martinez
Chief Operating Officer
Chief Operating Officer
15.01K
+53.84%
Mr. Emiliano Sosa
Mr. Emiliano Sosa
Chief Technology Officer
Chief Technology Officer
10.00K
--
Mr. Anthony B. Petrelli
Mr. Anthony B. Petrelli
Non-Employee Independent Director
Non-Employee Independent Director
--
--
Mr. Michael J. Sardano, J.D.
Mr. Michael J. Sardano, J.D.
President, General Counsel, Corporate Secretary, Chief Commercial Officer, Director
President, General Counsel, Corporate Secretary, Chief Commercial Officer, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Joseph C. Sardano
Mr. Joseph C. Sardano
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
1.20M
+2.13%
Mr. Eric Sachetta
Mr. Eric Sachetta
Independent Director
Independent Director
140.11K
--
Mr. Javier Rampolla
Mr. Javier Rampolla
Chief Financial Officer
Chief Financial Officer
40.00K
-1.82%
Ms. Megan Cornish
Ms. Megan Cornish
Non-Employee Independent Director
Non-Employee Independent Director
32.00K
--
Ms. Magdalena Martinez
Ms. Magdalena Martinez
Chief Operating Officer
Chief Operating Officer
15.01K
+53.84%
Mr. Emiliano Sosa
Mr. Emiliano Sosa
Chief Technology Officer
Chief Technology Officer
10.00K
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Product Revenue
5.75M
78.58%
Service Revenue
1.57M
21.42%
By RegionUSD
Name
Revenue
Proportion
United States
6.71M
91.76%
China
587.00K
8.02%
others
16.00K
0.22%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Product Revenue
5.75M
78.58%
Service Revenue
1.57M
21.42%
Shareholding Stats
Updated: Wed, Nov 26
Updated: Wed, Nov 26
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Solot (Edwin L)
7.58%
Sardano (Joseph C)
7.31%
The Vanguard Group, Inc.
4.44%
Pacific Ridge Capital Partners, LLC
3.49%
Dimensional Fund Advisors, L.P.
3.47%
Other
73.72%
Shareholders
Shareholders
Proportion
Solot (Edwin L)
7.58%
Sardano (Joseph C)
7.31%
The Vanguard Group, Inc.
4.44%
Pacific Ridge Capital Partners, LLC
3.49%
Dimensional Fund Advisors, L.P.
3.47%
Other
73.72%
Shareholder Types
Shareholders
Proportion
Individual Investor
18.26%
Investment Advisor
14.03%
Investment Advisor/Hedge Fund
11.46%
Hedge Fund
1.76%
Pension Fund
1.61%
Research Firm
0.28%
Family Office
0.08%
Other
52.51%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
125
4.72M
28.74%
-1.24M
2025Q2
140
7.09M
43.13%
-2.09M
2025Q1
154
7.13M
43.39%
-2.80M
2024Q4
147
7.94M
48.11%
-1.27M
2024Q3
150
7.10M
43.29%
-2.85M
2024Q2
154
6.60M
40.18%
-2.53M
2024Q1
151
6.11M
37.21%
-3.18M
2023Q4
151
6.25M
38.07%
-3.71M
2023Q3
150
6.30M
38.34%
-3.97M
2023Q2
150
6.99M
42.55%
-3.21M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Solot (Edwin L)
1.25M
7.57%
-288.00K
-18.78%
Dec 31, 2024
Sardano (Joseph C)
1.18M
7.15%
--
--
Apr 10, 2025
The Vanguard Group, Inc.
740.02K
4.5%
--
--
Jun 30, 2025
Pacific Ridge Capital Partners, LLC
454.76K
2.77%
+340.26K
+297.17%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
602.48K
3.66%
+60.75K
+11.21%
Jun 30, 2025
Divisadero Street Capital Management, LP
324.67K
1.97%
+266.63K
+459.41%
Jun 30, 2025
Florida State Board of Administration
189.67K
1.15%
+122.09K
+180.67%
Jun 30, 2025
Renaissance Technologies LLC
250.13K
1.52%
-9.50K
-3.66%
Jun 30, 2025
Driehaus Capital Management, LLC
237.91K
1.45%
+53.67K
+29.13%
Aug 31, 2025
Acadian Asset Management LLC
377.41K
2.3%
-93.31K
-19.82%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0.01%
DFA Dimensional US Sustainability Core 1 ETF
0%
Dimensional US Core Equity 1 ETF
0%
Avantis US Small Cap Value ETF
0%
DFA Dimensional US Small Cap Value ETF
0%
Avantis US Small Cap Equity ETF
0%
Lattice Hartford Multifactor Small Cap ETF
0%
iShares Micro-Cap ETF
Proportion0.01%
DFA Dimensional US Sustainability Core 1 ETF
Proportion0%
Dimensional US Core Equity 1 ETF
Proportion0%
Avantis US Small Cap Value ETF
Proportion0%
DFA Dimensional US Small Cap Value ETF
Proportion0%
Avantis US Small Cap Equity ETF
Proportion0%
Lattice Hartford Multifactor Small Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Sensus Healthcare Inc?
The top five shareholders of Sensus Healthcare Inc are:
Solot (Edwin L) holds 1.25M shares, accounting for 7.57% of the total shares.
Sardano (Joseph C) holds 1.18M shares, accounting for 7.15% of the total shares.
The Vanguard Group, Inc. holds 740.02K shares, accounting for 4.50% of the total shares.
Pacific Ridge Capital Partners, LLC holds 454.76K shares, accounting for 2.77% of the total shares.
Dimensional Fund Advisors, L.P. holds 602.48K shares, accounting for 3.66% of the total shares.
Solot (Edwin L) holds 1.25M shares, accounting for 7.57% of the total shares.
Sardano (Joseph C) holds 1.18M shares, accounting for 7.15% of the total shares.
The Vanguard Group, Inc. holds 740.02K shares, accounting for 4.50% of the total shares.
Pacific Ridge Capital Partners, LLC holds 454.76K shares, accounting for 2.77% of the total shares.
Dimensional Fund Advisors, L.P. holds 602.48K shares, accounting for 3.66% of the total shares.
What are the top three shareholder types of Sensus Healthcare Inc?
The top three shareholder types of Sensus Healthcare Inc are:
Solot (Edwin L)
Sardano (Joseph C)
The Vanguard Group, Inc.
Solot (Edwin L)
Sardano (Joseph C)
The Vanguard Group, Inc.
How many institutions hold shares of Sensus Healthcare Inc (SRTS)?
As of 2025Q3, 125 institutions hold shares of Sensus Healthcare Inc, with a combined market value of approximately 4.72M, accounting for 28.74% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -14.39%.
What is the biggest source of revenue for Sensus Healthcare Inc?
In FY2025Q2, the Product Revenue business generated the highest revenue for Sensus Healthcare Inc, amounting to 5.75M and accounting for 78.58% of total revenue.
